These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 17318034)

  • 1. Living with an implantable cardioverter defibrillator: patient outcomes and the nurse's role.
    Sossong A
    J Cardiovasc Nurs; 2007; 22(2):99-104. PubMed ID: 17318034
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determinants of the quality of life (QoL) in patients with an implantable cardioverter/defibrillator (ICD).
    Godemann F; Butter C; Lampe F; Linden M; Werner S; Behrens S
    Qual Life Res; 2004 Mar; 13(2):411-6. PubMed ID: 15085913
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term quality of life and uncertainty in patients living with an implantable cardioverter defibrillator.
    Flemme I; Edvardsson N; Hinic H; Jinhage BM; Dalman M; Fridlund B
    Heart Lung; 2005; 34(6):386-92. PubMed ID: 16324957
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Longitudinal changes in quality of life following ICD implant and the impact of age, gender, and ICD shocks: observations from the INTRINSIC RV trial.
    Gopinathannair R; Lerew DR; Cross NJ; Sears SF; Brown S; Olshansky B
    J Interv Card Electrophysiol; 2017 Apr; 48(3):291-298. PubMed ID: 28220279
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcomes, problems and quality of life with the implantable cardioverter defibrillator.
    Reid SS; McKinley S; Nagy S
    Aust J Adv Nurs; 1999; 16(4):14-9. PubMed ID: 10603767
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multi-morbidity burden, psychological distress, and quality of life in implantable cardioverter defibrillator recipients: Results from a nationwide study.
    Miller JL; Thylén I; Elayi SC; Etaee F; Fleming S; Czarapata MM; Lennie TA; Moser DK
    J Psychosom Res; 2019 May; 120():39-45. PubMed ID: 30929706
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and evaluation of the EOL-ICDQ as a measure of experiences, attitudes and knowledge in end-of-life in patients living with an implantable cardioverter defibrillator.
    Thylén I; Wenemark M; Fluur C; Strömberg A; Bolse K; Årestedt K
    Eur J Cardiovasc Nurs; 2014 Apr; 13(2):142-51. PubMed ID: 24298191
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characteristics associated with anxiety, depressive symptoms, and quality-of-life in a large cohort of implantable cardioverter defibrillator recipients.
    Thylén I; Dekker RL; Jaarsma T; Strömberg A; Moser DK
    J Psychosom Res; 2014 Aug; 77(2):122-7. PubMed ID: 25077853
    [TBL] [Abstract][Full Text] [Related]  

  • 9. "Hosting" an implantable cardioverter defibrillator: A phenomenological inquiry.
    Garrino L; Borraccino A; Peraudo E; Bobbio M; Dimonte V
    Res Nurs Health; 2018 Feb; 41(1):57-68. PubMed ID: 29171061
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exploring uncertainty and psychosocial adjustment after cardioverter defibrillator implantation.
    Mauro AM
    J Cardiovasc Nurs; 2008; 23(6):527-35. PubMed ID: 18953218
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Implantable cardioverter-defibrillators in lamin A/C mutation carriers with cardiac conduction disorders.
    Anselme F; Moubarak G; Savouré A; Godin B; Borz B; Drouin-Garraud V; Gay A
    Heart Rhythm; 2013 Oct; 10(10):1492-8. PubMed ID: 23811080
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quality of life in the antiarrhythmics versus implantable defibrillators trial: impact of therapy and influence of adverse symptoms and defibrillator shocks.
    Schron EB; Exner DV; Yao Q; Jenkins LS; Steinberg JS; Cook JR; Kutalek SP; Friedman PL; Bubien RS; Page RL; Powell J
    Circulation; 2002 Feb; 105(5):589-94. PubMed ID: 11827924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A review of the evidence on the effects and costs of implantable cardioverter defibrillator therapy in different patient groups, and modelling of cost-effectiveness and cost-utility for these groups in a UK context.
    Buxton M; Caine N; Chase D; Connelly D; Grace A; Jackson C; Parkes J; Sharples L
    Health Technol Assess; 2006 Aug; 10(27):iii-iv, ix-xi, 1-164. PubMed ID: 16904046
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Costs and quality-of-life effects of implantable cardioverter-defibrillators.
    Groeneveld PW; Matta MA; Suh JJ; Heidenreich PA; Shea JA
    Am J Cardiol; 2006 Nov; 98(10):1409-15. PubMed ID: 17134641
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Implantable cardioverter defibrillator recipients: quality of life in recipients with and without ICD shock delivery: a prospective study.
    Kamphuis HC; de Leeuw JR; Derksen R; Hauer RN; Winnubst JA
    Europace; 2003 Oct; 5(4):381-9. PubMed ID: 14753636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ICD: a qualitative study of patient experience the first year after implantation.
    Kamphuis HC; Verhoeven NW; Leeuw R; Derksen R; Hauer RN; Winnubst JA
    J Clin Nurs; 2004 Nov; 13(8):1008-16. PubMed ID: 15533107
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reconstructing unpredictability: experiences of living with an implantable cardioverter defibrillator over time.
    Morken IM; Severinsson E; Karlsen B
    J Clin Nurs; 2010 Feb; 19(3-4):537-46. PubMed ID: 19886873
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fear of exercise and health-related quality of life in patients with an implantable cardioverter defibrillator.
    van Ittersum M; de Greef M; van Gelder I; Coster J; Brügemann J; van der Schans C
    Int J Rehabil Res; 2003 Jun; 26(2):117-22. PubMed ID: 12799605
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Perceptions of Singaporean patients living with implantable cardioverter defibrillators: an exploratory qualitative study.
    Ooi SL; Seah B; Wu VX; Koh KWL; Jiao N; He HG; Wang W
    Heart Lung; 2018; 47(4):329-336. PubMed ID: 29724613
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of Chronic Total Coronary Occlusion on Recurrence of Ventricular Arrhythmias in Ischemic Secondary Prevention Implantable Cardioverter-Defibrillator Recipients (VACTO Secondary Study): Insights From Coronary Angiogram and Electrogram Analysis.
    Nombela-Franco L; Iannaccone M; Anguera I; Amat-Santos IJ; Sanchez-Garcia M; Bautista D; Calvelo MN; Di Marco A; Moretti C; Pozzi R; Scaglione M; Cañadas V; Sandin-Fuentes M; Arenal A; Bagur R; Perez-Castellano N; Fernandez-Perez C; Gaita F; Macaya C; Escaned J; Fernández-Lozano I
    JACC Cardiovasc Interv; 2017 May; 10(9):879-888. PubMed ID: 28473110
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.